Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients

SIMPLE SUMMARY: For patients with advanced basal cell carcinoma (aBCC) limited treatment options are available. In this situation, hedgehog inhibitors (HHIs) are approved as first-line treatment. Upon treatment failure or intolerance, a second-line treatment with PD1 inhibitors (PD1i) is an option....

Descripción completa

Detalles Bibliográficos
Autores principales: DeTemple, Viola K., Hassel, Jessica C., Sachse, Michael M., Grimmelmann, Imke, Leiter, Ulrike, Gebhardt, Christoffer, Eckardt, Julia, Pföhler, Claudia, Angela, Yenny, Hübbe, Hanna, Gutzmer, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658899/
https://www.ncbi.nlm.nih.gov/pubmed/36358887
http://dx.doi.org/10.3390/cancers14215469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658899/
https://www.ncbi.nlm.nih.gov/pubmed/36358887
http://dx.doi.org/10.3390/cancers14215469

Ejemplares similares